MEDIC

Anticancer chemotherapy has had some similarities to gunfire range-finding: too much, then too little to find the effective “shot” somewhere in between. But genomics is beginning to reveal how an individual’s metabolism figures in drug dosing, and biochemical engineers at the University of California at Santa Barbara have developed an in vivo microfluidics/electrochemical biosensor that can continuously detect drug concentrations in whole blood, and thus be able to indicate a patient’s metabolic rate.  This is a significant contribution to the concept of personalized medicine.  MORE

Image Credit:  MobileHealthNews.com